These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6420136)

  • 1. Adverse dermatologic reaction to transdermal nitroglycerin.
    Letendre PW; Barr C; Wilkens K
    Drug Intell Clin Pharm; 1984 Jan; 18(1):69-70. PubMed ID: 6420136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative evaluation of two transdermal nitroglycerin delivery systems: Nitro-Dur versus Transderm-Nitro. The Collaborative Investigation Group.
    Clin Ther; 1991; 13(5):545-9. PubMed ID: 1799911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin acceptance of transcutaneous nitroglycerin patches: a prospective study of 33 patients.
    Vaillant L; Biette S; Machet L; Constans T; Monpère C
    Contact Dermatitis; 1990 Sep; 23(3):142-5. PubMed ID: 2126502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe allergic contact dermatitis secondary to nitroglycerin in a transdermal therapeutic system.
    Topaz O; Abraham D
    Ann Allergy; 1987 Nov; 59(5):365-6. PubMed ID: 3120627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved skin adherence and patient acceptance in a new transdermal nitroglycerin delivery system.
    Hougham AJ; Hawkinson RW; Crowley JK; Wilson RR; Glode JE; Hilty RW; Hughes SO; Koeppl CG; Kovaric TR; Wyskoarko NP
    Clin Ther; 1989; 11(1):23-31. PubMed ID: 2497985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allergic contact dermatitis secondary to transdermal nitroglycerin.
    Rosenfeld AS; White WB
    Am Heart J; 1984 Oct; 108(4 Pt 1):1061-2. PubMed ID: 6237565
    [No Abstract]   [Full Text] [Related]  

  • 7. Adhesion-to-skin performance of a new transdermal nitroglycerin adhesive patch.
    Wick KA; Wick SM; Hawkinson RW; Holtzman JL
    Clin Ther; 1989; 11(3):417-24. PubMed ID: 2501033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of adhesive properties of two transdermal nitroglycerin controlled-release systems.
    Chinoy DA; Breaux PC; Ibrahim F
    Clin Ther; 1985; 8(1):30-4. PubMed ID: 3938681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occupational allergic contact dermatitis caused by nitroglycerin.
    Kanerva L; Laine R; Jolanki R; Tarvainen K; Estlander T; Helander I
    Contact Dermatitis; 1991 May; 24(5):356-62. PubMed ID: 1832616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter comparison of adhesion, preference, tolerability, and safety characteristics of two transdermal nitroglycerin delivery systems: Transderm-Nitro and Deponit.
    Chinoy DA; Camp J; Elchahal S; Godoy C; Grossman W; Hai H; Hamilton W; Kushner M; McGreevy M; Mulvihill RJ
    Clin Ther; 1989; 11(5):678-84. PubMed ID: 2509071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intermittent transdermal nitroglycerin on occurrence of ischemia after patch removal: results of the second transdermal intermittent dosing evaluation study (TIDES-II).
    Pepine CJ; Lopez LM; Bell DM; Handberg-Thurmond EM; Marks RG; McGorray S
    J Am Coll Cardiol; 1997 Oct; 30(4):955-61. PubMed ID: 9316524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal nitroglycerin systems: methods for comparison.
    Harrison LI; Riedel DJ
    Clin Ther; 1991; 13(3):361-7. PubMed ID: 1954637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variational analysis of the transdermal delivery rate from two prototypical ethanol-water nitroglycerin TTS devices and Transderm-Nitro 10 in the normal population.
    Kochak GM; Berner B; Leal M; Sambol NC
    J Pharmacokinet Biopharm; 1992 Oct; 20(5):443-59. PubMed ID: 1287196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of two transdermal nitroglycerin systems: Transderm-Nitro and Nitro-Dur.
    Riley S; Morris B; Walker L; Reese P; White L
    Clin Ther; 1992; 14(3):438-45. PubMed ID: 1638585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acceptance of transcutaneous nitroglycerin patches by patients with angina pectoris.
    Schrader BJ; Bauman JL; Zeller FP; Shanes JG; Rich S
    Pharmacotherapy; 1986; 6(2):83-6. PubMed ID: 3086849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of nitroglycerin and clonidine delivered by the transdermal route.
    Shaw JE
    Am Heart J; 1984 Jul; 108(1):217-23. PubMed ID: 6428208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of two transdermal nitroglycerin systems.
    Godoy C; Greenspahn BR; Kushner MJ; Lahti RE; Levy RA; Reese P; Reynolds GM; Rice SC
    Clin Ther; 1986; 8(6):689-93. PubMed ID: 3098427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allergic contact dermatitis from transdermal nitroglycerin.
    Carmichael AJ; Foulds IS
    Contact Dermatitis; 1989 Aug; 21(2):113-4. PubMed ID: 2530050
    [No Abstract]   [Full Text] [Related]  

  • 19. Improved comfort and patient acceptance in a novel transdermal nitroglycerin delivery system.
    Hougham AJ; Hawkinson RW; Crowley JK; Wilson RR; Brown SG; Dougherty PJ; Fogel MA; Hash VW; Rietbrock MJ
    Clin Ther; 1989; 11(1):15-22. PubMed ID: 2497982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative acceptance of three transdermal nitroglycerin placebo patches.
    Rayment CM; Kaul AF; Garfield JM
    Am J Hosp Pharm; 1985 Jun; 42(6):1362-5. PubMed ID: 3925770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.